Antibody Response to the Coronavirus Disease 2019 Ad26.COV2.S Vaccine Among Maintenance Dialysis Patients

• Linda H. Ficociello, DSc,
• Joanna Willetts, MS,
• Claudy Mullon, PhD,
• Chance Mysayphonh, PharmD,
• Ines A. Dahne-Steuber, MA,
• Curtis Johnson, MS,
• Melanie Pollan, PhD,
• Sandra Alexander, BS,
• Jeffrey G. Mulhern, MD,
• Robert J. Kossmann, MD,
• Michael S. Anger, MD,
• Jeffrey L. Hymes, MD

Affiliations

Linda H. Ficociello, DSc

Fresenius Medical Care, Global Medical Office, Medical Department, Fresenius Medical Care Renal Therapies Group, Waltham, MA

Joanna Willetts, MS

Fresenius Medical Care, Global Medical Office, Medical Department, Fresenius Medical Care Renal Therapies Group, Waltham, MA

Claudy Mullon, PhD

Medical Department, Fresenius Medical Care Renal Therapies Group, Waltham, MA

Chance Mysayphonh, PharmD

Fresenius Medical Care, Global Medical Office, Medical Department, Fresenius Medical Care Renal Therapies Group, Waltham, MA

Ines A. Dahne-Steuber, MA

Spectra Laboratories, Rockleigh, NJ

Curtis Johnson, MS

Spectra Laboratories, Milpitas, CA

Melanie Pollan, PhD

Siemens Healthcare Diagnostics Inc, Tarrytown, NY

Sandra Alexander, BS

Fresenius Medical Care North America, Waltham

Jeffrey G. Mulhern, MD

Baystate Medical Center, Springfield, MA

Robert J. Kossmann, MD

Fresenius Medical Care, Global Medical Office, Medical Department, Fresenius Medical Care Renal Therapies Group, Waltham, MA

Michael S. Anger, MD

Fresenius Medical Care, Global Medical Office, Medical Department, Fresenius Medical Care Renal Therapies Group, Waltham, MA; Medical Department, Fresenius Medical Care Renal Therapies Group, Waltham, MA

Jeffrey L. Hymes, MD

Fresenius Medical Care, Global Medical Office, Medical Department, Fresenius Medical Care Renal Therapies Group, Waltham, MA; Address for Correspondence: Jeffrey L. Hymes, MD, 1000 Corporate Centre Drive, Suite 400, Franklin, TN 37067.